Covid-19 vaccines
Please read the latest reassurance from our Medical Director, Professor Ley Sander around epilepsy and the covid-19 vaccines. We also have a full Q&A around the vaccines which is regularly updated.
We are Epilepsy Society. The UK's leading charity for epilepsy research and support.
Due to current circumstances in relation to the coronavirus some of our services have been reduced with our staff working from home. Despite this our top priority at Epilepsy Society is to support people living with epilepsy. You may notice a slight change in our communications. For the time being, we will focus our efforts on making sure you have all the information you need from us to help you as best we can in the current climate.
Leading care provider
Our range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Cutting edge research
Epilepsy Society's Chalfont Centre is unique in bringing together intellectual capital to form a powerhouse multidisciplinary team who contribute to a wide ranging spectrum of research.
Epilepsy Support
Our confidential epilepsy helpline and online information give help and support to people who are affected by epilepsy.
Advocacy
We are a voice for people with epilepsy, striving to push epilepsy up the political agenda and bring about change at government level.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Join us to make your voice heard and help improve the lives of people with epilepsy. Through our advocacy campaigns we've spread awareness of the impact of epilepsy on people's lives and protected people with epilepsy by lobbying government.
Latest news
“Alarming” new study raises SUDEP concerns
The Epilepsy Society has expressed alarm about the doubling of Sudden Unexpected Death in Epilepsy (SUDEP) in pregnant and postnatal women.
Covid-19 vaccine - Q&A
As vaccines for the Covid-19 virus are rolled out across the UK, the Department of Health and Social Care answers your questions including who will receive the vaccine, can you choose which one and will the vaccine prevent transmission?
Vaccine offers hope for family visits
This is our amazing research team who put their day jobs on hold to help deliver the Covid-19 vaccine to almost all of the residents living at the Epilepsy Society.
Review looks at risks associated with epilepsy drugs during pregnancy
A new review has been published looking at risks associated with the most commonly prescribed anti-epileptic medications during pregnancy.
Zonisamide 25/50/100mg out of stock
We have been informed by Teva UK that Zonisamide 25/50/100mg is currently out of stock.
Medication update
We have been informed by Teva UK that Zonisamide 25/50/100mg is currently out of stock.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email
helpline@epilepsysociety.org.uk.
Please support us.
In these challenging times, charities like Epilepsy Society rely on donations to ensure vital services for our beneficiaries can continue. If you can spare a donation or pledge a monthly gift, you will be helping to ensure we continue to support everyone affected by epilepsy. Thank you.